Valuation : Steris PLC

Market Cap 2.21TCr 1.9TCr 1.79TCr 1.63TCr 3.05TCr 2,09100Cr 3.07TCr 21TCr 8.23TCr 1,06800Cr 8.3TCr 8.12TCr 3,44100Cr P/E 2027 *
24.4x
P/E 2028 * 21.7x
Enterprise Value 2.35TCr 2.02TCr 1.9TCr 1.73TCr 3.24TCr 2,21900Cr 3.26TCr 22TCr 8.73TCr 1,13400Cr 8.81TCr 8.62TCr 3,65200Cr EV / Sales 2027 *
3.68x
EV / Sales 2028 * 3.41x
Free-Float
99.69%
Yield 2027 *
1.17%
Yield 2028 * 1.27%
Manager TitleAgeSince
Chief Executive Officer 53 29/07/2021
Director of Finance/CFO 59 18/08/2025
Compliance Officer - 01/08/2019
Director TitleAgeSince
Director/Board Member 73 01/03/2005
Director/Board Member 54 01/05/2018
Chairman 67 28/07/2018
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%-.--% - - 2.21TCr
-1.52%-2.51%-17.70%+5.78% 19TCr
+1.00%+3.48%+0.92%+13.36% 12TCr
+0.26%+4.98%+14.26%+92.74% 6.44TCr
-0.74%-0.53%+23.13%+47.66% 5.26TCr
+0.05%-0.27%-1.05%-32.62% 5.11TCr
+0.02%+0.47%+13.67%-11.96% 3.39TCr
+0.80%+5.60% - - 3.21TCr
+0.03%-0.97%+37.67%-15.93% 2.41TCr
-0.95%-3.82%-6.99%+12.43% 2.34TCr
Average +0.06%+0.09%+7.99%+13.93% 6.54TCr
Weighted average by Cap. -0.24%-0.57%+0.12%+16.14%

Financials

2027 *2028 *
Net sales 637.22Cr 548.27Cr 514.5Cr 470.73Cr 878.59Cr 60TCr 885.55Cr 6.09TCr 2.37TCr 31TCr 2.39TCr 2.34TCr 99TCr 677.76Cr 583.14Cr 547.23Cr 500.67Cr 934.48Cr 64TCr 941.88Cr 6.47TCr 2.52TCr 33TCr 2.55TCr 2.49TCr 1,05400Cr
Net income 89Cr 76Cr 72Cr 66Cr 122.54Cr 8.4TCr 123.51Cr 848.9Cr 330.6Cr 4.29TCr 333.75Cr 326.47Cr 14TCr 101.91Cr 88Cr 82Cr 75Cr 140.52Cr 9.63TCr 141.63Cr 973.42Cr 379.09Cr 4.92TCr 382.71Cr 374.36Cr 16TCr
Net Debt 135.61Cr 116.68Cr 109.5Cr 100.18Cr 186.98Cr 13TCr 188.46Cr 1.3TCr 504.44Cr 6.55TCr 509.26Cr 498.15Cr 21TCr 102.11Cr 88Cr 82Cr 75Cr 140.78Cr 9.65TCr 141.9Cr 975.27Cr 379.81Cr 4.93TCr 383.43Cr 375.07Cr 16TCr
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-